newsfilter
← Latest News
GlobeNewswire·

Amryt Supports Rare Disease Day 2022

Amryt Supports Rare Disease Day 2022 DUBLIN, Ireland, and Boston MA, February 25, 2022, Amryt (NASDAQ:AMYT), a global, commercial-stage biopharmaceutical company focussed on acquiring, developing and commercializing novel treatments for rare diseases,